BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37149425)

  • 1. Prediction of Radiation-induced Lymphopenia following Exposure of the Thoracic Region and Associated Risk of Infections and Mortality.
    Terrones-Campos C; Ledergerber B; Forbes N; Smith AG; Petersen J; Helleberg M; Lundgren J; Specht L; Vogelius IR
    Clin Oncol (R Coll Radiol); 2023 Jul; 35(7):e434-e444. PubMed ID: 37149425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte Count Kinetics, Factors Associated with the End-of-Radiation-Therapy Lymphocyte Count, and Risk of Infection in Patients with Solid Malignant Tumors Treated with Curative-Intent Radiation Therapy.
    Terrones-Campos C; Ledergerber B; Vogelius IR; Specht L; Helleberg M; Lundgren J
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):812-823. PubMed ID: 31344435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematological toxicity in patients with solid malignant tumors treated with radiation - Temporal analysis, dose response and impact on survival.
    Terrones-Campos C; Ledergerber B; Vogelius IR; Helleberg M; Specht L; Lundgren J
    Radiother Oncol; 2021 May; 158():175-183. PubMed ID: 33662438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes.
    Tang C; Liao Z; Gomez D; Levy L; Zhuang Y; Gebremichael RA; Hong DS; Komaki R; Welsh JW
    Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1084-1091. PubMed ID: 25035212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk and impact of radiation related lymphopenia in lung cancer: A systematic review and meta-analysis.
    Upadhyay R; Venkatesulu BP; Giridhar P; Kim BK; Sharma A; Elghazawy H; Dhanireddy B; Elumalai T; Mallick S; Harkenrider M
    Radiother Oncol; 2021 Apr; 157():225-233. PubMed ID: 33577865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy.
    Chen D; Patel RR; Verma V; Ramapriyan R; Barsoumian HB; Cortez MA; Welsh JW
    Radiother Oncol; 2020 Sep; 150():114-120. PubMed ID: 32525003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton and Carbon Ion Radiation Therapy Decreased Severe Lymphopenia by Reducing Thoracic Vertebra and Aortic Doses in Non-Small Cell Lung Cancer Versus Intensity Modulated Radiation Therapy.
    Li Y; Fan X; Yu Q; Zhai H; Mo M; Sun J; Mi J; Lu R; Mao J; Chen J; Ma N; Yang W; Zhu J; Jiang G; Wu K
    Int J Radiat Oncol Biol Phys; 2023 Jul; 116(3):579-589. PubMed ID: 36586495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-treatment lymphocytopaenia, integral body dose and overall survival in lung cancer patients treated with radical radiotherapy.
    Joseph N; McWilliam A; Kennedy J; Haslett K; Mahil J; Gavarraju A; Mistry H; Van Herk M; Faivre-Finn C; Choudhury A
    Radiother Oncol; 2019 Jun; 135():115-119. PubMed ID: 31015156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors.
    Pike LRG; Bang A; Mahal BA; Taylor A; Krishnan M; Spektor A; Cagney DN; Aizer AA; Alexander BM; Rahma O; Balboni T; Ott PA; Hodi FS; Schoenfeld JD
    Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):142-151. PubMed ID: 30227198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vertebral body and splenic irradiation are associated with lymphopenia in localized pancreatic cancer treated with stereotactic body radiation therapy.
    Reddy AV; Deek MP; Jackson JF; Hill CS; Sehgal S; He J; Zheng L; Herman JM; Meyer J; Narang AK
    Radiat Oncol; 2021 Dec; 16(1):242. PubMed ID: 34952610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shortened Radiation Time Promotes Recovery From Radiation-induced Lymphopenia in Early-Stage Non-small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
    Zhao Q; Li T; Du S; He J; Zeng Z
    Technol Cancer Res Treat; 2022; 21():15330338221112287. PubMed ID: 35816375
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of Radiation Dose to the Host Immune System on Tumor Control and Survival for Stage III Non-Small Cell Lung Cancer Treated with Definitive Radiation Therapy.
    Ladbury CJ; Rusthoven CG; Camidge DR; Kavanagh BD; Nath SK
    Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):346-355. PubMed ID: 31175902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lymphoid volume irradiation on radiation-induced lymphopenia in head and neck cancers.
    Césaire M; Rambeau A; Cherifi F; Géry B; Johnson A; Nacher M; Thariat J
    Cancer Radiother; 2023 Apr; 27(2):145-153. PubMed ID: 36759240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte sparing normal tissue effects in the clinic (LymphoTEC): A systematic review of dose constraint considerations to mitigate radiation-related lymphopenia in the era of immunotherapy.
    Venkatesulu B; Giridhar P; Pujari L; Chou B; Lee JH; Block AM; Upadhyay R; Welsh JS; Harkenrider MM; Krishnan S; Verma V; En Hsieh C; Pradhan S; Small W; Solanki AA
    Radiother Oncol; 2022 Dec; 177():81-94. PubMed ID: 36334694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of lymphopenia on survival in proton therapy with chemotherapy for non-small cell lung cancer.
    Nakamura M; Ishikawa H; Ohnishi K; Mori Y; Baba K; Nakazawa K; Shiozawa T; Sekine I; Maruo K; Okumura T; Sakurai H
    J Radiat Res; 2023 Mar; 64(2):438-447. PubMed ID: 36592478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy.
    Deng W; Xu C; Liu A; van Rossum PSN; Deng W; Liao Z; Koong AC; Mohan R; Lin SH
    Radiother Oncol; 2019 Apr; 133():9-15. PubMed ID: 30935587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe radiation-induced lymphopenia during concurrent chemoradiotherapy for stage III non-small cell lung cancer: external validation of two prediction models.
    van Rossum PSN; Juan-Cruz C; Stam B; Rossi MMG; Lin SH; Abravan A; Belderbos JSA; Sonke JJ
    Front Oncol; 2023; 13():1278723. PubMed ID: 38023221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation Induced Lymphopenia Is Associated With the Effective Dose to the Circulating Immune Cells in Breast Cancer.
    Chen F; Jin JY; Hui TSK; Jing H; Zhang H; Nong Y; Han Y; Wang W; Ma L; Yi F; Chen Q; Zhang Y; Fu P; Yang L; Xu Z; Kong FS
    Front Oncol; 2022; 12():768956. PubMed ID: 35600350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Determinants for Radiation-Induced Lymphopenia in Patients With Breast Cancer Using Interpretable Machine Learning Approach.
    Yu H; Chen F; Lam KO; Yang L; Wang Y; Jin JY; Ei Helali A; Kong FS
    Front Immunol; 2022; 13():768811. PubMed ID: 35799797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy?
    Chadha AS; Liu G; Chen HC; Das P; Minsky BD; Mahmood U; Delclos ME; Suh Y; Sawakuchi GO; Beddar S; Katz MH; Fleming JB; Javle MM; Varadhachary GR; Wolff RA; Crane CH; Wang X; Thames H; Krishnan S
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):323-332. PubMed ID: 28068240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.